In order to investigate the potential role of UBXN1 in modulating the NF‐κB signaling pathway in GC cells, the impact of UBXN1 knockdown on NF‐κB signaling was assessed via western blot analysis. The gene discussed is NFKB1; the disease is gastric cancer.